Citation 65219

SATO,A: SHINDO,T: KASANUKI,N: HASEGAWA,K:. (1989). ANTIOXIDANT METABOLITES FROM THE TUNICATE AMAROUCIUM MULTIPLICATUM.. 52(5)

Citation Details

Title	ANTIOXIDANT METABOLITES FROM THE TUNICATE AMAROUCIUM MULTIPLICATUM.
Authors	SATO,A: SHINDO,T: KASANUKI,N: HASEGAWA,K:
Year	1989
Volume	52
Issue	5

Summary

Year: 1989

Journal: Unknown

Organisms and Their Experiments (1)

Amaroucium multiplicatum (SYNOICIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZOPYRAN-2H-1: 6-HYDROXY-7-METHOXY-2-METHYL-2-(4-METHYL-PENT-3-ENYL):	None
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-2H-1: 6-HYDROXY-7-METHOXY-2-METHYL-2-(4-METHYL-PENT-3-ENYL):	ACTIVE
6	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-2H-1: 6-HYDROXY-7-METHOXY-2-METHYL-2-(4-METHYL-PENT-3-ENYL):	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZENE-1-4-DIOL,2-(3-HYDROXY-3-7-DIMETHYL-OCT-6-ENYL):	None
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZENE-1-4-DIOL,2-(3-HYDROXY-3-7-DIMETHYL-OCT-6-ENYL):	ACTIVE
9	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZENE-1-4-DIOL,2-(3-HYDROXY-3-7-DIMETHYL-OCT-6-ENYL):	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZENE-1-4-DIOL,2-(3-HYDROXY-3-7-DIMETHYL-OCT-2-6-DIENYL):	None
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZENE-1-4-DIOL,2-(3-HYDROXY-3-7-DIMETHYL-OCT-2-6-DIENYL):	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHROMEN-6-OL,2H: 2-METHYL-2-(4-METHYL-PENT-3-ENYL):	None
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMEN-6-OL,2H: 2-METHYL-2-(4-METHYL-PENT-3-ENYL):	ACTIVE
14	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMEN-6-OL,2H: 2-METHYL-2-(4-METHYL-PENT-3-ENYL):	ACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GERANYLHYDROQUINONE	None
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANYLHYDROQUINONE	ACTIVE
17	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANYLHYDROQUINONE	ACTIVE

Show SPARQL Queries (1)